Skip to main content

Table 4 Impact of PSMA PET/CT staging and level of confidence on a per-patient level. n = 64 patients

From: Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

N stage

N Status

LoCa

up

15 (23%)

9 (14%)

down

6 (9%)

3 (5%)

no change

43 (67%)

52 (81%)

M stage

M Status

LoCa

up

8 (13%)

15 (23%)

down

15 (23%)

2 (3%)

no change

41 (64%)

47 (73%)

  1. aLoC: imaging-based level of confidence in correct assessment of N and M status
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us